Cloning and high level nonfusion expression of recombinant human basic fibroblast growth factor in Escherichia coli.
Abstract
AIM: To obtain high-level expression of nonfusion recombinant human basic
fibroblast growth factor (rhbFGF).
METHODS: hbFGF cDNA was prepared from the total RNA of embryonic brain tissue. As
a template, the obtained gene was used to clone nonfusion rhbFGF. New primers
were employed to alter the translation initiation region (TIR) and reduce the G+C
content through nucleotide change. Using pET-3C as vector, the cloned rhbFGF was
expressed in BL21 (DE3).
RESULTS: rhbFGF was expressed in E coli up to 30 % of the total cellular protein.
Cation exchange and heparin affinity chromatography were employed to purify the
target protein from the supernatant of bacteria lysate. The bioactivity of the
purified rhbFGF was identical with the standard bFGF.
CONCLUSION: Modification of TIR is an effective means to increase nonfusion
expression rate of recombinant proteins, such as rhbFGF, in E coli.
Keywords:
fibroblast growth factor (rhbFGF).
METHODS: hbFGF cDNA was prepared from the total RNA of embryonic brain tissue. As
a template, the obtained gene was used to clone nonfusion rhbFGF. New primers
were employed to alter the translation initiation region (TIR) and reduce the G+C
content through nucleotide change. Using pET-3C as vector, the cloned rhbFGF was
expressed in BL21 (DE3).
RESULTS: rhbFGF was expressed in E coli up to 30 % of the total cellular protein.
Cation exchange and heparin affinity chromatography were employed to purify the
target protein from the supernatant of bacteria lysate. The bioactivity of the
purified rhbFGF was identical with the standard bFGF.
CONCLUSION: Modification of TIR is an effective means to increase nonfusion
expression rate of recombinant proteins, such as rhbFGF, in E coli.